[New medications for treatment of erectile dysfunction].
Nagai
Atsushi
A
Department of Urology, Okayama University Graduate School of Medicine and Dentistry.
Kumon
Hiromi
H
D001120:Arginine / Q000494:pharmacology; D002243:Carbolines; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D010410:Penile Erection / Q000187:drug effects*; D010456:Peptides, Cyclic / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D020110:Pinacidil / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D013450:Sulfones; D000068581:Tadalafil; D014227:Triazines; D000069058:Vardenafil Dihydrochloride; D014665:Vasodilator Agents / Q000494:pharmacology; D000521:alpha-MSH / Q000031:analogs & derivatives* / Q000494:pharmacology
D002243:Carbolines; D007093:Imidazoles; D010456:Peptides, Cyclic; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D013450:Sulfones; D014227:Triazines; D014665:Vasodilator Agents; C079282:melanotan-II; D000521:alpha-MSH; D000069058:Vardenafil Dihydrochloride; D000068581:Tadalafil; D020110:Pinacidil; D001120:Arginine